Company Filing History:
Years Active: 2024
Title: Jori Wehrmuller: Innovator in Antibody-Payload Conjugation
Introduction
Jori Wehrmuller is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of methods for generating antibody-payload conjugates.
Latest Patents
Jori Wehrmuller holds 1 patent for his invention titled "Transglutaminase conjugation method and linker." This innovative method utilizes microbial transglutaminase (MTG) to create an antibody-payload conjugate. The process involves conjugating a linker with a primary amine residue to a Gln residue in the heavy or light chain of an antibody.
Career Highlights
Jori Wehrmuller is affiliated with the Paul Scherrer Institut, where he conducts research and development in the field of biochemistry. His work focuses on enhancing the efficacy of antibody-based therapies through innovative conjugation techniques.
Collaborations
He collaborates with esteemed colleagues such as Philipp Rene Spycher and Roger Schibli, contributing to advancements in their shared field of research.
Conclusion
Jori Wehrmuller is a prominent figure in the biotechnology sector, recognized for his innovative methods in antibody conjugation. His work continues to influence the development of targeted therapies in medicine.